176 related articles for article (PubMed ID: 25333456)
21. Synergistic effect of bromocriptine and tumor necrosis factor-alpha on reversing hepatocellular carcinoma multidrug resistance in nude mouse MDR1 model of liver neoplasm.
Ding L; Chen XP; Zhang ZW; Guan J; Zhang WG; Wang HP; Wang ZH; Li CL
World J Gastroenterol; 2005 Sep; 11(36):5621-6. PubMed ID: 16237754
[TBL] [Abstract][Full Text] [Related]
22. Reversal effect of arsenic sensitivity in human leukemia cell line K562 and K562/ADM using realgar transforming solution.
Wang X; Zhang X; Xu Z; Wang Z; Yue X; Li H
Biol Pharm Bull; 2013; 36(4):641-8. PubMed ID: 23358330
[TBL] [Abstract][Full Text] [Related]
23. Synergistic Effect of Baicalin and Adriamycin in Resistant HL-60/ADM Leukaemia Cells.
Zheng J; Asakawa T; Chen Y; Zheng Z; Chen B; Lin M; Liu T; Hu J
Cell Physiol Biochem; 2017; 43(1):419-430. PubMed ID: 28869936
[TBL] [Abstract][Full Text] [Related]
24. Effect and mechanism of resveratrol on drug resistance in human bladder cancer cells.
Wang S; Meng Q; Xie Q; Zhang M
Mol Med Rep; 2017 Mar; 15(3):1179-1187. PubMed ID: 28098863
[TBL] [Abstract][Full Text] [Related]
25. ABCG2 gene amplification and expression in esophageal cancer cells with acquired adriamycin resistance.
Liu L; Zuo LF; Guo JW
Mol Med Rep; 2014 Apr; 9(4):1299-304. PubMed ID: 24535197
[TBL] [Abstract][Full Text] [Related]
26. Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562/ADM cells by suppressing MDR1 gene/P-glycoprotein expression.
Pan J; Miao D; Chen L
Chem Biol Interact; 2018 May; 288():32-37. PubMed ID: 29655913
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the multi-drug resistant human hepatocellular carcinoma cell line Bel-7402/ADM model established by three methods.
Zhong X; Xiong M; Meng X; Gong R
J Exp Clin Cancer Res; 2010 Aug; 29(1):115. PubMed ID: 20727186
[TBL] [Abstract][Full Text] [Related]
28. Ultrasound reverses multidrug resistance in human cancer cells by altering gene expression of ABC transporter proteins and Bax protein.
Wu F; Shao ZY; Zhai BJ; Zhao CL; Shen DM
Ultrasound Med Biol; 2011 Jan; 37(1):151-9. PubMed ID: 21084157
[TBL] [Abstract][Full Text] [Related]
29. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.
Chao CC
FEBS Lett; 1995 Oct; 373(3):285-90. PubMed ID: 7589484
[TBL] [Abstract][Full Text] [Related]
30. Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.
Naito S; Hasegawa S; Yokomizo A; Koga H; Kotoh S; Kuwano M; Kumazawa J
Jpn J Cancer Res; 1995 Nov; 86(11):1112-8. PubMed ID: 8567404
[TBL] [Abstract][Full Text] [Related]
31. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
Rieger L; Rieger J; Winter S; Streffer J; Esser P; Dichgans J; Meyermann R; Weller M
Acta Neuropathol; 2000 May; 99(5):555-62. PubMed ID: 10805101
[TBL] [Abstract][Full Text] [Related]
32. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.
Grandjean F; Brémaud L; Verdier M; Robert J; Ratinaud MH
Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872
[TBL] [Abstract][Full Text] [Related]
33. Reversing multidrug-resistant by RNA interference through silencing MDR1 gene in human hepatocellular carcinoma cells subline Bel-7402/ADM.
Sheng L; Xiong M; Li C; Meng X
Pathol Oncol Res; 2014 Jul; 20(3):541-8. PubMed ID: 24327315
[TBL] [Abstract][Full Text] [Related]
34. Multidrug resistance: molecular mechanisms and clinical relevance.
Ling V
Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
[TBL] [Abstract][Full Text] [Related]
35. Multidrug resistance-associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion.
Barrand MA; Bagrij T; Neo SY
Gen Pharmacol; 1997 May; 28(5):639-45. PubMed ID: 9184795
[TBL] [Abstract][Full Text] [Related]
36. Chemoresistance in gliomas.
Lu C; Shervington A
Mol Cell Biochem; 2008 May; 312(1-2):71-80. PubMed ID: 18259841
[TBL] [Abstract][Full Text] [Related]
37. Grape seed proanthocyanidin extract reverses multidrug resistance in HL-60/ADR cells via inhibition of the PI3K/Akt signaling pathway.
Lin KN; Jiang YL; Zhang SG; Huang SY; Li H
Biomed Pharmacother; 2020 May; 125():109885. PubMed ID: 32007917
[TBL] [Abstract][Full Text] [Related]
38. Resistance to topoisomerase II inhibitors in human glioma cell lines overexpressing multidrug resistant associated protein (MRP) 2.
Matsumoto Y; Tamiya T; Nagao S
J Med Invest; 2005 Feb; 52(1-2):41-8. PubMed ID: 15751272
[TBL] [Abstract][Full Text] [Related]
39. Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma.
Haga S; Hinoshita E; Ikezaki K; Fukui M; Scheffer GL; Uchiumi T; Kuwano M
Jpn J Cancer Res; 2001 Feb; 92(2):211-9. PubMed ID: 11223551
[TBL] [Abstract][Full Text] [Related]
40. JNK1, JNK2, and JNK3 are involved in P-glycoprotein-mediated multidrug resistance of hepatocellular carcinoma cells.
Yan F; Wang XM; Liu ZC; Pan C; Yuan SB; Ma QM
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):287-95. PubMed ID: 20525557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
